Keiretsu Capital

Keiretsu Capital, established in 2013 and headquartered in Seattle with an additional office in San Francisco, is a private equity firm specializing in early-stage investments. It focuses on sectors such as life science, healthcare, technology, and real estate. The firm leverages its association with Keiretsu Forum, the world's largest angel investor network, to provide access to proprietary deal flow and facilitate investments in high-quality emerging companies. Keiretsu Capital aims to enhance the value of these investments by assisting in their presentation to various investors, including syndicate partners, venture capitalists, corporate investors, and public markets, with the goal of achieving significant capital appreciation.

Clinton Pinto

Managing Director

276 past transactions

MiClient

Seed Round in 2024
MiClient offers a proposal generation application that streamlines the management of proposals and client onboarding for businesses in the service sector. The platform simplifies document creation and lead management, enhancing workflow efficiency to improve sales conversion rates. With various built-in proposal templates, MiClient makes it easier for businesses to create winning proposals and track their deals, ultimately facilitating faster closure of transactions. Additionally, the application automates the client onboarding process and enhances the payment collection experience, making it a comprehensive solution for service-oriented organizations.

Healionics

Series A in 2023
Healionics Corporation, founded in 2007 and based in Seattle, Washington, specializes in the development and manufacturing of synthetic biomaterials and implantable medical devices aimed at improving healthcare for kidney failure patients. The company has created STARport HD, an implantable device that enables needle-free access to the bloodstream for hemodialysis, and STARgraft, a synthetic vascular graft designed to maintain long-term blood flow without frequent interventions. Healionics' innovations address critical challenges in dialysis treatment, particularly the unreliability of current vascular access methods, which can lead to costly complications. Their STAR biomaterial technology enhances the performance of medical implants by reducing infection and scar tissue formation. Healionics is preparing to initiate human studies for its products, with a focus on improving patient outcomes and reducing overall treatment costs in the dialysis sector.

Clensta

Venture Round in 2023
Clensta is an Indian biotechnology start-up focused on enhancing national hygiene standards while promoting water conservation. In collaboration with IIT Delhi, Clensta develops innovative healthcare solutions aimed at making hygiene accessible to everyone, regardless of their location. The company offers a range of hygiene products, including sanitizers, waterless shampoo, and waterless body baths, designed to minimize the use of water and reduce the reliance on single-use plastics. By providing effective personal care solutions, Clensta enables individuals to maintain high levels of cleanliness and well-being in an environmentally sustainable manner.

Another Tomorrow

Series A in 2023
Another Tomorrow is a sustainable luxury brand launched in January 2020, focused on reinventing the fashion industry through a digitally-native and tech-enabled approach. The brand emphasizes transparency in its product ecosystem, offering authenticated resale options and a foundation for ongoing innovation. As the first luxury fashion brand to achieve B-Corp certification, Another Tomorrow prioritizes environmentally responsible practices while aiming to serve societal needs. Future plans include expanding into marketplace extensions. The brand has garnered significant media attention, being featured in prominent publications such as The New York Times, Bloomberg, and Vogue, highlighting its commitment to sustainability and ethical fashion.

EarthGrid PBC

Seed Round in 2023
EarthGrid is pioneering a novel approach to tunneling, trenching, and excavation through its patented plasma tunnel-boring technology. This innovative method utilizes high-power plasma torches to vaporize and break down materials such as rock and clay, enabling significantly faster operations and substantial cost savings compared to conventional techniques. The company's network of tunnels aims to enhance infrastructure and connectivity within communities by facilitating the movement of clean renewable energy, extending broadband access to underserved areas, and providing essential services like clean water and efficient transportation for e-commerce. EarthGrid's comprehensive infrastructure solutions are designed to create interconnected and sustainable environments, fostering improved access and quality of life for communities.

The Hotel Communication Network

Series A in 2023
Founded in 2008 and headquartered in Ottawa, Ontario, The Hotel Communication Network specializes in in-room hospitality technology aimed at enhancing guest experiences. The company has developed innovative solutions that enable guests to interact seamlessly with hotel systems, their rooms, and the surrounding city. This technology allows guests to make purchases, order room service, report issues, and control various room features, fostering real-time communication between hotels and their guests. Additionally, it serves as a powerful tool for hotels to promote their brands and marketing initiatives effectively.

Tenzr Health

Convertible Note in 2023
Tenzr Health focuses on enhancing musculoskeletal wellness and recovery through the use of intelligent wearable sensors and digital technology. The company develops precise, real-time guidance tools, including wearable wristbands equipped with sensors that connect via Bluetooth to an application. This technology enables physical therapists and patients to engage in digital-physical therapy from the comfort and safety of their homes. By combining healthcare expertise with gamification elements, Tenzr Health aims to motivate and guide both clinicians and patients, ultimately promoting more effective rehabilitation processes.

Buoy

Seed Round in 2023
Buoy is a manufacturer of hydrating wellness drops designed to enhance any beverage by adding essential electrolytes, vitamins, ionic trace minerals, and antioxidants. Recognizing that many individuals struggle to drink the recommended daily water intake, Buoy provides a solution that transforms ordinary drinks into functional beverages. The drops dissolve instantly and evenly, allowing users to improve their hydration without altering the taste of their favorite drinks. This product addresses the widespread issue of chronic dehydration, which affects a significant portion of the population and can lead to symptoms such as low energy, headaches, and increased blood pressure. By incorporating Buoy's drops, customers can effectively replenish lost electrolytes caused by various everyday activities, thereby promoting better hydration and overall wellness.

Tend Health

Convertible Note in 2023
Tend Health offers an innovative device for the safe, standardized, convenient processing of a stool sample into capsules for therapeutic use. In addition, Tend offers personalized gut microbiome analysis for patients and clinicians.

Turn Technologies

Seed Round in 2023
Turn Technologies, Inc. is a Chicago-based company that specializes in developing an AI-powered workforce-as-a-service platform aimed at managing workers. Founded in 2016, the company focuses on hiring hourly, shift-based, and contracted workers, utilizing advanced screening and AI sourcing techniques. Its platform is designed for speed and accuracy, offering features such as mobile-friendly services, seamless API and HR integration, flexibility in planning, comprehensive candidate profiles, and built-in support tools. This comprehensive approach allows companies to efficiently source, screen, and retain workers, enhancing their workforce management capabilities.

NuvOx Pharma

Convertible Note in 2023
NuvOx Pharma is a pharmaceutical company focused on developing a drug platform designed to enhance oxygen delivery in the body, particularly for treating life-threatening diseases. The company's innovative approach involves intravenous injections that allow the drug to first accumulate in the lungs, where it picks up oxygen, before reaching hypoxic tissues to deliver that oxygen passively. This technology aims to address critical medical conditions such as stroke, certain oncological diseases, and sickle cell crisis. The drug is currently in various stages of clinical readiness, with indications for stroke and oncology at Phase II and sickle cell crisis at Phase Ib. NuvOx Pharma strives to improve oxygen flow from the lungs to the bloodstream and subsequently to tissues, thereby enabling healthcare providers to better manage hypoxia-related complications.

Kineta

Post in 2023
Kineta, Inc. is a clinical stage biotechnology company based in Seattle, Washington, focused on the development of immunology-based therapeutics for oncology, neuroscience, and virology. The company is advancing a range of innovative therapies, including KCP-506, a non-opioid antagonist for chronic pain, and LHF-535, an oral antiviral targeting Lassa and other arenaviruses by inhibiting viral entry and replication. Kineta is also engaged in developing next-generation immunotherapies, exemplified by KVA12.1, a VISTA blocking immunotherapy designed to reprogram the immune system to combat cancer. With strategic partnerships with notable organizations like Pfizer and Genentech, Kineta aims to leverage its expertise in antiviral therapies and immune modulation to address significant medical challenges. Formerly known as Lecura, Inc., the company was founded in 2007.

Stracker Solar

Convertible Note in 2023
Stracker Solar specializes in the manufacturing, selling, and installation of advanced elevated dual-axis solar trackers. These innovative solar setups are designed to maximize solar energy production, providing both consumers and businesses with enhanced efficiency in harnessing renewable energy. By focusing on cutting-edge technology, Stracker Solar aims to facilitate greater adoption of solar energy solutions.

Votegrity

Convertible Note in 2023
Votegrity is a Seattle-based company founded in 2020 that provides online election services designed to enhance voter accessibility and confidence in the electoral process. Its platform employs end-to-end verification and cryptographic technology to ensure that each ballot is counted as intended while protecting voter privacy. By allowing voters to cast their votes from computers or smart devices, Votegrity aims to create a more informed electorate and streamline the voting experience. Additionally, the platform contributes to environmental sustainability by reducing paper usage associated with traditional voting methods.

Arbutus Medical

Grant in 2023
Arbutus Medical Inc., founded in 2014 and headquartered in Vancouver, Canada, specializes in the development and manufacturing of surgical power tools aimed at enhancing surgical efficiency and accessibility. The company offers a range of products, including its flagship orthopedic power tool system, which features innovative solutions such as the HEX and PRO drill kits, as well as sterile-packed orthopedic procedure kits. These tools are designed to meet the needs of various healthcare settings, including trauma centers, veterinary hospitals, military deployments, and hospitals in over 30 low- and middle-income countries. Arbutus Medical focuses on "frugal innovation," aiming to reduce healthcare costs and improve access to orthopedic surgery for millions of patients by 2030.

SpIntellx

Convertible Note in 2023
SpIntellx, Inc. is a computational and systems pathology company based in Pittsburgh, Pennsylvania, specializing in spatial intelligence software products for cancer diagnosis. Established in 2017, the company offers innovative solutions such as SpIntellx, which analyzes image data sets from various imaging platforms and reagent types, enabling precise analysis of pathology tissue sections. Additionally, SpIntellx provides HistoMapr, a computational guide for pathologists, and TumorMapr, which examines the spatial interactions of biomarkers within whole slide images using multiplexed fluorescence. By leveraging unbiased spatial analytics powered by explainable AI, SpIntellx aims to enhance the understanding of complex cancer biology, contributing to advancements in medicine and research across drug development, diagnostics, and treatment pipelines.

Volan Technology

Seed Round in 2022
The Volan Positioning System (VPS) is an advanced micro-location and geofencing technology that enables unprecedented improvements in operational efficiency, security and safety for major airports, large warehousing/logistics companies, and commercial and civil construction. Using our patented 100% wireless mesh technology, VPS delivers precise location positioning and analytics on 1000s of moving assets, resources, and people indoors, outdoors, and underground. This affordable enterprise scale solution can be deployed in just a few hours with zero impact on IT departments or infrastructure.

ActX

Seed Round in 2022
ActX, Inc. is a company based in Seattle, Washington, founded in 2012, that specializes in integrating genomic information into clinical practice. The company focuses on providing actionable clinical insights derived from patients' genetic data, which helps healthcare providers personalize medical care. ActX offers services that include the collection and analysis of saliva samples, ensuring that genetic information is securely stored and privately managed. This enables physicians to access relevant genomic insights either through electronic medical records or a secure online platform, thereby enhancing patient care and improving health outcomes.

Loopr AI

Convertible Note in 2022
Loopr AI, founded in 2021 and based in Bellevue, Washington, offers a no-code artificial intelligence platform aimed at streamlining business automation for organizations of various sizes. The platform allows businesses to implement pre-built AI solutions quickly, often within hours or days, facilitating the resolution of complex challenges through AI-driven processes and advanced machine learning techniques. By leveraging Loopr AI's tools, organizations can enhance quality, reduce operational costs, and automate a wide range of processes across different industries and functions.

Turn Technologies

Convertible Note in 2022
Turn Technologies, Inc. is a Chicago-based company that specializes in developing an AI-powered workforce-as-a-service platform aimed at managing workers. Founded in 2016, the company focuses on hiring hourly, shift-based, and contracted workers, utilizing advanced screening and AI sourcing techniques. Its platform is designed for speed and accuracy, offering features such as mobile-friendly services, seamless API and HR integration, flexibility in planning, comprehensive candidate profiles, and built-in support tools. This comprehensive approach allows companies to efficiently source, screen, and retain workers, enhancing their workforce management capabilities.

DecisionNext

Series A in 2022
DecisionNext, Inc. is a provider of a cloud-based predictive analytics platform tailored for commodities-driven businesses, including sectors such as minerals, agribusiness, fishing, forestry, oil, and gas. Established in 2013 and headquartered in San Francisco, California, with an additional office in Brisbane, Australia, the company focuses on enhancing decision-making processes for its clients. The platform offers a range of solutions, including commodity price forecasting, purchasing optimization, product mix optimization, capacity optimization, and pricing and promotion optimization. By integrating these functionalities into a unified system, DecisionNext enables clients to improve end-to-end performance, maximize profit margins, and reduce uncertainty through real-time validation of forecasting models and simulation of market scenarios.

Archax

Series A in 2022
Archax Ltd is a London-based digital securities exchange that specializes in trading asset-backed tokens, including digital securities and security tokens. Established in 2018, it is recognized as the UK's first regulated digital securities exchange, broker, and custodian, having received authorization from the Financial Conduct Authority. Archax aims to serve institutional investors by providing a secure platform for trading various digital assets, from cryptocurrencies to digital securities. The exchange is designed to integrate seamlessly with existing institutional trading workflows and operates on high-performance infrastructure hosted in top-tier data centers. By bridging the gap between the blockchain-centric technology community and traditional investment sectors, Archax facilitates safe trading among recognized participants in a regulated environment.

FEMSelect

Series B in 2022
FEMSelect Inc. specializes in designing and developing surgical systems and devices for pelvic floor ligament fixation, focusing on women's health. The company is known for its innovative EnPlace system, a minimally invasive and mesh-free solution for treating pelvic organ prolapse (POP). This patented technology allows for precise guidance and deployment of an anchor unit that stabilizes the pelvic floor ligament through a vaginal approach, significantly enhancing patient recovery and comfort. The procedure typically takes about 30 minutes and does not require overnight hospital stays or result in visible scarring. Founded in 2012, FEMSelect operates from its headquarters in Newark, Delaware.

Carmell Cosmetics

Series C in 2022
Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repaired tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).

Yellow Card

Series B in 2022
Yellow Card operates as a leading digital currency exchange platform in Africa, specializing in the buying and selling of stablecoins such as USDT, USDC, and PYUSD. It serves individuals and businesses across 20 countries, offering secure and cost-effective methods for transactions using local currencies. The platform has facilitated over $3 billion in transactions, contributing to the growth of cryptocurrency adoption on the continent. Yellow Card collaborates with local merchants and vendors to provide vouchers that can be redeemed for Bitcoin, allowing customers to transfer money and engage in e-commerce. This integration enables individuals to participate in the digital economy, simplifying access to cryptocurrency for a broader audience.

Shyft

Series B in 2022
Shyft Moving Inc. is a mobility technology company that specializes in relocation management solutions for corporations and relocation service providers. Founded in 2015 and based in San Francisco with an additional office in Belgrade, Serbia, Shyft offers a mobile application designed to simplify the relocation process for employees. The company’s innovative platform integrates various services, including housing searches and pricing transparency, to facilitate seamless relocations worldwide. With a focus on enhancing customer experience, Shyft serves over 300 moving companies across more than 68 countries, helping them manage leads and improve service delivery. The company aims to transform the moving industry by providing efficient, technology-driven solutions that streamline the entire moving process, from initial inquiries to final invoicing.

Archax

Venture Round in 2022
Archax Ltd is a London-based digital securities exchange that specializes in trading asset-backed tokens, including digital securities and security tokens. Established in 2018, it is recognized as the UK's first regulated digital securities exchange, broker, and custodian, having received authorization from the Financial Conduct Authority. Archax aims to serve institutional investors by providing a secure platform for trading various digital assets, from cryptocurrencies to digital securities. The exchange is designed to integrate seamlessly with existing institutional trading workflows and operates on high-performance infrastructure hosted in top-tier data centers. By bridging the gap between the blockchain-centric technology community and traditional investment sectors, Archax facilitates safe trading among recognized participants in a regulated environment.

React Mobile

Convertible Note in 2022
React Mobile, Inc. is a Seattle-based company that develops a personal safety smartphone application tailored for the hospitality industry and other sectors such as healthcare, transportation, education, and logistics. The application includes features like Follow-Me, which allows users to share their real-time location with friends and family, and The React Sidekick, a personal panic button that connects users to a network in emergencies. The platform is designed to enhance workplace safety by enabling quick response times; in the event of an alert, it sends notifications with GPS coordinates to emergency contacts via text and email, facilitating rapid assistance. React Mobile's offerings are especially relevant in the context of workplace safety regulations, such as those mandating panic buttons for hotel workers in Seattle. Founded in 2011, the company's focus is on ensuring employee safety and efficient emergency response.

Aprea

Post in 2022
Aprea is a biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The Company's lead program, APR-246, is a first-in-class small molecule drug candidate in clinical development. Aprea Therapeutics was established in 2003 in Stockholms Lan, Sweden by Klas Wiman and Galina Selivanova.

Atrin Pharmaceuticals

Series A in 2022
Atrin Pharmaceuticals LLC is a biopharmaceutical company based in Doylestown, Pennsylvania, focused on the discovery and development of innovative cancer treatments. Founded in 2011, the company is developing its lead drug candidates, ATRN-502, a p53 activator, and ATRN-507, a dual ligand that selectively targets cancer cells. Atrin is also advancing a proprietary platform called Atrize, which utilizes phenotypic FACS-based screening for rapid identification of effective drug candidates and evaluation of personalized medicine approaches. The company's research aims to address cancers linked to synthetic lethality and deregulated DNA damage response, with a focus on creating treatments that are effective against cancer cells while minimizing impact on healthy cells. Through its innovative methodologies, Atrin Pharmaceuticals seeks to change the landscape of cancer therapy.

KEY Concierge

Series C in 2022
KEY Concierge is a technology company based in Austin, Texas, established in 2014. It operates a platform that offers on-demand concierge services to travelers, including hotel recommendations and personal assistance. The company serves a diverse client base, comprising property managers, boutique hotels, and the private aviation sector. KEY's business model facilitates a three-sided marketplace, connecting travelers, vacation rental properties, and local vendors.

Lumoptik

Seed Round in 2022
Lumoptik has developed a light-based needle guidance platform designed to assist physicians in performing medical procedures with enhanced precision. The company's initial product is a needle guidance system specifically for epidural procedures, which are commonly used in childbirth and pain management. This system is user-friendly and cost-effective, featuring an electronic controller and disposable sterile fiber optics. It aims to provide real-time visual guidance, reducing the complications associated with needle placement and improving overall success rates. Lumoptik is currently producing the commercial version for clinical trials and has engaged with regulatory authorities regarding its launch, which is anticipated in mid-2021. Additionally, the company has conducted a proof-of-concept animal trial for a second product aimed at guiding the placement of pedicle screws during spine surgeries, showcasing the versatility of its platform technology.

Ethicann Pharmaceuticals

Convertible Note in 2022
Ethicann Pharmaceuticals uses pharmaceutical-grade botanically sourced cannabinoid oils to formulate ethical drugs. It targets several different large-market diseases for its THC+CBD ethical pharmaceutical drugs; namely and in order of launch, spasticity from multiple sclerosis, adult focal epilepsy, chemotherapy-induced nausea and vomiting (CINV), and chronic pain from cancer.

CamDo Solutions

Seed Round in 2022
CamDo Solutions specializes in enhancing the functionality and versatility of GoPro cameras through a range of innovative photographic products. The company develops and markets solutions such as time-lapse cameras, battery eliminators, solar power systems, weatherproof enclosures, deep water housings, underwater Wi-Fi extenders, and bullet time slice rigs. These products are designed to enable consumers, professionals, and organizations, including notable clients like NASA and National Geographic, to capture unique and challenging footage with ease. By focusing on custom solutions, CamDo Solutions aims to push the boundaries of traditional camera capabilities, allowing users to monitor environmental applications and undertake complex photography and videography tasks effectively.

Oticara

Convertible Note in 2022
Oticara is a pharmaceutical company focused on developing enhanced antifungal products aimed at addressing unmet medical needs, particularly in the treatment of chronic sinusitis and related conditions. The company's offerings target common bacterial and fungal pathogens responsible for otitis externa, thereby providing healthcare professionals with effective treatment options for patients experiencing sinus and ear issues. Led by a team of experienced executives in pharmaceutical development, Oticara is dedicated to delivering innovative solutions to improve patient outcomes in the realm of ear and sinus health.

Votegrity

Convertible Note in 2022
Votegrity is a Seattle-based company founded in 2020 that provides online election services designed to enhance voter accessibility and confidence in the electoral process. Its platform employs end-to-end verification and cryptographic technology to ensure that each ballot is counted as intended while protecting voter privacy. By allowing voters to cast their votes from computers or smart devices, Votegrity aims to create a more informed electorate and streamline the voting experience. Additionally, the platform contributes to environmental sustainability by reducing paper usage associated with traditional voting methods.

Sonavex

Series A in 2022
Sonavex, Inc. is a Baltimore-based company founded in 2013 that specializes in advanced imaging technology aimed at enhancing surgical outcomes. The company has developed a proprietary ultrasound-based platform that enables clinicians to detect anastomotic blood clots and assess critical intravascular flow metrics directly at the point of care. This technology not only facilitates the measurement of blood flow and vessel morphology but also includes bioresorbable and echogenic equipment to mark at-risk blood vessels for future assessments. By providing actionable data, Sonavex supports healthcare providers in monitoring and improving patient care, particularly in the context of post-operative complications.

Inmedix

Seed Round in 2022
Inmedix, LLC is a company focused on developing diagnostics and therapeutics for autoimmune diseases by assessing and optimizing the autonomic nervous system's (ANS) control of stress responses in the brain. Founded in 2006 and located in Normandy Park, Washington, Inmedix has introduced a novel class of diagnostics and therapeutics aimed at understanding the relationship between ANS stress and autoimmune conditions. This approach, termed Immuno-autonomics, seeks to mitigate the exacerbating effects of stress on autoimmune diseases, enhancing the efficacy of existing therapies. Inmedix offers a cloud-based software platform along with diagnostic devices that track the interaction between stress and immune function, providing valuable insights for clinicians and opportunities in drug discovery.

ActX

Convertible Note in 2022
ActX, Inc. is a company based in Seattle, Washington, founded in 2012, that specializes in integrating genomic information into clinical practice. The company focuses on providing actionable clinical insights derived from patients' genetic data, which helps healthcare providers personalize medical care. ActX offers services that include the collection and analysis of saliva samples, ensuring that genetic information is securely stored and privately managed. This enables physicians to access relevant genomic insights either through electronic medical records or a secure online platform, thereby enhancing patient care and improving health outcomes.

LumiThera

Debt Financing in 2022
LumiThera, Inc. is a medical device company dedicated to developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Founded in 2013 and based in Poulsbo, Washington, the company specializes in photobiomodulation therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular disorders. Its flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular conditions. LumiThera's technology not only strives to halt or slow the progression of vision-threatening diseases but also aims to enhance visual acuity and contrast sensitivity in patients. Through its advancements in light therapy, LumiThera supports healthcare providers in offering improved treatment options for individuals affected by these common eye disorders.

My911

Venture Round in 2021
Automatic Accident and Emergency Response, Personal GPS Tracker, Mobile GPS Tracking, Roadside Assistance cell phone solution. Visit www.my-911.com for more in

SageMedic

Series A in 2021
SageMedic Corporation, based in Redwood City, California, specializes in developing innovative solutions for cancer treatment through its SAGE Direct Platform. Established in 2017, the company focuses on creating three-dimensional micro-tumors from live cancer tissue biopsies obtained from patients. This technology allows for direct testing of approved cancer therapies on the generated micro-tumors, enabling physicians to evaluate treatment responses and identify the most effective options for individual patients. By employing a genome-free approach, SageMedic aims to enhance precision medicine and improve patient outcomes in cancer therapy.

InfiniteWorld

Convertible Note in 2021
InfiniteWorld is a provider of Web3 and Metaverse infrastructure designed to enhance brand engagement and monetization for creators and businesses. The company operates a carbon-negative NFT platform that facilitates interaction between brands and their audiences through both real-world and virtual products, events, and interactive experiences. Its software enables users to manage physical collectibles alongside digital NFTs, creating a comprehensive digital closet. Additionally, InfiniteWorld offers tools and features for brands to collaborate effectively within its marketplace, allowing them to design and launch highly interactive NFTs. This approach fosters community engagement while ensuring the authentication of digital identities.

KitoTech Medical

Series B in 2021
KitoTech Medical is a medical device company based in Seattle, Washington, focused on developing and commercializing innovative products for wound closure and care. The company's flagship product, microMend, features a unique design that incorporates tiny Microstaples on an adhesive backing, resembling a butterfly bandage. This product is painless to apply and offers the holding strength of traditional sutures, making it suitable for closing surgical incisions and lacerations. Clinical studies indicate that microMend outperforms sutures in various clinical outcomes, including cosmetic results, and can be applied more quickly by a range of medical personnel, resulting in significant cost savings. microMend is marketed across numerous surgical specialties, as well as in dermatology and emergency medicine, with additional commercialization efforts targeting military applications. The potential market for microMend is substantial, estimated at over $600 million in the U.S. and around $2 billion globally. KitoTech Medical was founded in 2011.

Alpin

Seed Round in 2021
Alpin, Inc. is a company based in Boulder, Colorado, that develops a cloud identity management platform focused on monitoring and managing the software as a service (SaaS) ecosystem. The platform enables users to discover and manage their cloud software subscriptions, optimizing costs and renewing services while ensuring compliance and security. Alpin's solution provides a comprehensive view of SaaS subscriptions, highlighting areas of wasted spending and assisting in negotiating better deals. Additionally, it offers features for monitoring activity, archiving data, and alerting IT and security teams to potential risks. By streamlining SaaS management, Alpin aims to reduce subscription costs and enhance overall security for organizations navigating the complexities of cloud applications. The company was incorporated in 2015 and was previously known as Logrr, Inc.

Epilogue Systems

Series A in 2021
Epilogue Systems offers a B2B SaaS product called Opus, designed to assist organizations in creating, delivering, and managing user documentation for enterprise and complex applications. Opus automatically documents application workflows, transactions, and processes, generating outputs that are essential during the implementation phase—such as testing, compliance, and training—and providing in-application user guidance to enhance onboarding and proficiency post-launch. By enabling clients to develop end-user help resources and training materials, Epilogue Systems aims to improve application adoption and productivity, helping organizations achieve their operational goals effectively.

Pathware

Venture Round in 2021
Pathware Inc. specializes in developing automated point-of-care biopsy assessment systems aimed at enhancing the diagnostic capabilities of clinicians and pathologists. Its flagship product, Bioptic, allows for the rapid diagnosis of pathogens, while its sample management platform streamlines the pathology workflow by minimizing repetitive tasks. The company’s digital pathology platform integrates advanced hardware and software tools, facilitating immediate analysis of tissue samples at the point of care, thereby reducing the need to send samples to central laboratories. This innovation significantly shortens turnaround times and improves patient care through AI-powered image analysis and telepathology capabilities. Founded in 2017 and headquartered in Ann Arbor, Michigan, with an additional location in Seattle, Washington, Pathware is dedicated to improving healthcare by leveraging computational microscopy and artificial intelligence for more accurate and timely disease diagnosis and treatment.

Levered Learning

Venture Round in 2021
Levered Learning is an educational technology company founded in 2017 and based in Soquel, California. It specializes in an instructional system designed for 3rd to 5th grade mathematics education. The system is classroom-tested and teacher-designed, integrating whole-class discussions, collaborative pencil and paper activities, and online self-paced lessons. This blend supports both in-person and distance learning environments, enabling teachers to address learning gaps and enhance student performance in mathematics. Levered Learning aims to facilitate growth in elementary math through its comprehensive approach to instruction.

Tend Health

Venture Round in 2021
Tend Health offers an innovative device for the safe, standardized, convenient processing of a stool sample into capsules for therapeutic use. In addition, Tend offers personalized gut microbiome analysis for patients and clinicians.

Oticara

Convertible Note in 2021
Oticara is a pharmaceutical company focused on developing enhanced antifungal products aimed at addressing unmet medical needs, particularly in the treatment of chronic sinusitis and related conditions. The company's offerings target common bacterial and fungal pathogens responsible for otitis externa, thereby providing healthcare professionals with effective treatment options for patients experiencing sinus and ear issues. Led by a team of experienced executives in pharmaceutical development, Oticara is dedicated to delivering innovative solutions to improve patient outcomes in the realm of ear and sinus health.

KEY Concierge

Convertible Note in 2021
KEY Concierge is a technology company based in Austin, Texas, established in 2014. It operates a platform that offers on-demand concierge services to travelers, including hotel recommendations and personal assistance. The company serves a diverse client base, comprising property managers, boutique hotels, and the private aviation sector. KEY's business model facilitates a three-sided marketplace, connecting travelers, vacation rental properties, and local vendors.

Tenzr Health

Convertible Note in 2021
Tenzr Health focuses on enhancing musculoskeletal wellness and recovery through the use of intelligent wearable sensors and digital technology. The company develops precise, real-time guidance tools, including wearable wristbands equipped with sensors that connect via Bluetooth to an application. This technology enables physical therapists and patients to engage in digital-physical therapy from the comfort and safety of their homes. By combining healthcare expertise with gamification elements, Tenzr Health aims to motivate and guide both clinicians and patients, ultimately promoting more effective rehabilitation processes.

HaptX

Series A in 2021
HaptX develops advanced virtual reality gloves that simulate touch sensation with remarkable realism. By utilizing patented microfluidic technology, HaptX Gloves offer 130 points of touch feedback and provide resistive force feedback of 4 lbs. per finger while tracking hand motions with sub-millimeter precision. This innovative device creates a haptic experience that allows users to perceive the texture, shape, motion, vibration, and temperature of virtual objects, enhancing interaction within the virtual environment. Founded by Jake Rubin and Dr. Bob Crockett, HaptX operates with a team of 35 employees across offices in Seattle, Washington, and San Luis Obispo, California.

Steelhead Composites

Series A in 2021
Steelhead Composites LLC is an engineering and manufacturing company based in Golden, Colorado, specializing in lightweight hydraulic accumulators and high-pressure vessels for the hydraulic hybrid and energy storage markets. Founded in 2012, the company offers a range of services, including the manufacturing of aluminum cylinders, design and analysis of composite pressure vessels, and advanced filament winding techniques. Steelhead Composites also performs dynamic mechanical analysis, hydrostatic pressure testing, and precision 3D inspection of parts. With a fully digital shop floor and robust quality systems, the company competes in niche markets such as aerospace and hydrogen storage, providing safe and efficient solutions for storing and transporting gases in applications ranging from mobility to maritime.

Joule Case

Seed Round in 2021
Joule Case, Inc. designs and manufactures innovative battery and solar modules, providing scalable energy solutions that prioritize mobility and sustainability. Founded in 2015 and based in Seattle, Washington, the company offers a range of products, including various control and battery modules, which cater to diverse applications such as live events, electric vehicle fleet extension, construction sites, and portable food and beverage services. Joule Case's systems are engineered to integrate seamlessly with renewable energy sources, enabling users to minimize emissions and overcome traditional energy infrastructure limitations. The company's offerings promote a quieter, more efficient alternative to conventional gas generators while enhancing energy storage capabilities and adaptability to specific power needs.

Pattern Computer

Venture Round in 2021
Pattern Computer, Inc. is a pattern discovery company based in Friday Harbor, Washington, that specializes in uncovering insights from complex datasets. Founded in 2016, the company has developed a proprietary system that generates hypotheses and insights, enabling clients to tackle challenging problems in fields such as medical research and business analytics. Its platform is particularly noted for its application in breast cancer prognostics and the differentiation of healthy and disease-state pathways in microbiome and human gut disorders. By utilizing advanced techniques that surpass conventional methods, Pattern Computer aims to reveal novel patterns that can drive innovation and improve industry standards.

Healionics

Venture Round in 2021
Healionics Corporation, founded in 2007 and based in Seattle, Washington, specializes in the development and manufacturing of synthetic biomaterials and implantable medical devices aimed at improving healthcare for kidney failure patients. The company has created STARport HD, an implantable device that enables needle-free access to the bloodstream for hemodialysis, and STARgraft, a synthetic vascular graft designed to maintain long-term blood flow without frequent interventions. Healionics' innovations address critical challenges in dialysis treatment, particularly the unreliability of current vascular access methods, which can lead to costly complications. Their STAR biomaterial technology enhances the performance of medical implants by reducing infection and scar tissue formation. Healionics is preparing to initiate human studies for its products, with a focus on improving patient outcomes and reducing overall treatment costs in the dialysis sector.

Turn Technologies

Seed Round in 2021
Turn Technologies, Inc. is a Chicago-based company that specializes in developing an AI-powered workforce-as-a-service platform aimed at managing workers. Founded in 2016, the company focuses on hiring hourly, shift-based, and contracted workers, utilizing advanced screening and AI sourcing techniques. Its platform is designed for speed and accuracy, offering features such as mobile-friendly services, seamless API and HR integration, flexibility in planning, comprehensive candidate profiles, and built-in support tools. This comprehensive approach allows companies to efficiently source, screen, and retain workers, enhancing their workforce management capabilities.

Seneca Therapeutics

Venture Round in 2021
Seneca Therapeutics, Inc. is a biotechnology company based in Blue Bell, Pennsylvania, specializing in the development of oncolytic immunotherapeutics for cancer treatment. The company's primary product is the Seneca Valley Virus (SVV), an oncolytic virus designed to selectively replicate within and eliminate tumor cells. Seneca Therapeutics aims to advance SVV as a versatile therapeutic option, offering it in the form of cancer therapeutics, cancer vaccines, and vaccines for infectious diseases. Additionally, the company focuses on creating targeted biologics that can work in conjunction with immune checkpoint inhibitors and cancer vaccines, enhancing treatment efficacy and addressing immune tolerance in patients. Incorporated in 2018, Seneca Therapeutics is dedicated to providing innovative solutions for various types of cancer.

New View Surgical

Venture Round in 2021
New View Surgical, Inc. is a medical device company based in Boston, Massachusetts, that specializes in the development and commercialization of the VisionPort technology. This innovative system consolidates four essential surgical devices—a laparoscope, camera, light source, and access port—into a single, easy-to-use, and disposable unit. The VisionPort system aims to enhance minimally invasive surgical procedures by providing surgeons with complete control over visualization and instrumentation. Founded in 2009, the company is led by a team of experienced professionals dedicated to addressing unmet needs in the medical field, offering potential clinical and economic advantages for operating rooms worldwide.

Arcimoto

Post in 2021
Arcimoto is an automotive company based in the United States that specializes in the design, development, manufacturing, and sale of three-wheeled electric vehicles. The company's flagship product is the Fun Utility Vehicle (FUV), which offers an engaging ride experience for two passengers along with cargo capacity. Arcimoto's product lineup also includes the Rapid Responder, tailored for emergency and law enforcement services, and the Deliverator, an electric vehicle designed for last-mile deliveries. Additionally, the Cameo model is equipped for on-road filming, and the Arcimoto Roadster provides an exhilarating pure-electric driving experience. With a focus on sustainable transportation, Arcimoto aims to provide efficient alternatives to conventional gas-powered vehicles, significantly reducing environmental impact while catering to everyday driving needs.

Tilting Motor Works

Series A in 2021
Tilting Motor Works, Inc. specializes in developing leaning three-wheel conversion solutions for motorcycles, enhancing their stability and safety without compromising performance. Founded in 2008 and headquartered in Snohomish, Washington, the company replaces the front fork and wheel of traditional motorcycles with a new front end that integrates various components, including shocks, wheels, tires, brakes, and hydraulic systems. This patented retrofit aims to provide riders with an improved riding experience by offering higher performance and increased confidence on the road. With a focus on safety and stability, Tilting Motor Works continues to innovate in the motorcycle modification industry.

Pocket Naloxone

Seed Round in 2021
Pocket Naloxone is a pharmaceutical company focused on improving the delivery of naloxone, a life-saving antidote for opioid overdoses. The company offers over-the-counter naloxone hydrochloride products designed to enhance accessibility and affordability for individuals and clinicians. By exploring innovative dosage forms, Pocket Naloxone aims to contribute to the broader goal of eliminating opioid overdose deaths, enabling timely intervention in critical situations. Through its efforts, the company seeks to make a significant impact on public health and opioid overdose management.

Defunkify

Series A in 2021
Defunkify is a manufacturer of laundry cleaning and deodorizing products, specializing in solutions that effectively eliminate odors and stains from clothing and gear. Founded in 2017 and based in Eugene, Oregon, the company offers a range of products, including laundry detergent designed for activewear, as well as fabric and shoe deodorizers. Defunkify emphasizes the use of green chemistry to create high-performance products that are safer for consumers and the environment. Its offerings are available through various online platforms, including major retailers and its own website, ensuring a wide distribution across the United States. The innovative approach incorporates nano-engineered coatings that not only remove existing odors but also prevent them from returning, allowing users to wear clothing multiple times before needing to wash them.

Seneca Therapeutics

Venture Round in 2021
Seneca Therapeutics, Inc. is a biotechnology company based in Blue Bell, Pennsylvania, specializing in the development of oncolytic immunotherapeutics for cancer treatment. The company's primary product is the Seneca Valley Virus (SVV), an oncolytic virus designed to selectively replicate within and eliminate tumor cells. Seneca Therapeutics aims to advance SVV as a versatile therapeutic option, offering it in the form of cancer therapeutics, cancer vaccines, and vaccines for infectious diseases. Additionally, the company focuses on creating targeted biologics that can work in conjunction with immune checkpoint inhibitors and cancer vaccines, enhancing treatment efficacy and addressing immune tolerance in patients. Incorporated in 2018, Seneca Therapeutics is dedicated to providing innovative solutions for various types of cancer.

Inmedix

Seed Round in 2021
Inmedix, LLC is a company focused on developing diagnostics and therapeutics for autoimmune diseases by assessing and optimizing the autonomic nervous system's (ANS) control of stress responses in the brain. Founded in 2006 and located in Normandy Park, Washington, Inmedix has introduced a novel class of diagnostics and therapeutics aimed at understanding the relationship between ANS stress and autoimmune conditions. This approach, termed Immuno-autonomics, seeks to mitigate the exacerbating effects of stress on autoimmune diseases, enhancing the efficacy of existing therapies. Inmedix offers a cloud-based software platform along with diagnostic devices that track the interaction between stress and immune function, providing valuable insights for clinicians and opportunities in drug discovery.

Stor and Deliver

Venture Round in 2021
Stor and Deliver was founded to free you from the hassle of loading, hauling, and moving into storage. They provide full-service, concierge storage with a pickup at your door and on-demand return delivery for the cost of a traditional self-storage unit.

Vivia

Series B in 2020
Vivia Cares specializes in providing in-home care services for senior citizens, focusing on creating personalized care experiences. Their trained caregivers make regular visits to clients, allowing them to build trust and understand individual needs. The services offered include wellness checks, in-person prescription reminders, assistance with personal hygiene, and companionship. By bridging the gap between the expectations and realities of caregiving, Vivia Cares aims to enhance the quality of life for seniors, ensuring they receive the necessary support while fostering meaningful interactions.

iHealthHome

Series B in 2020
iHealthHome, LLC specializes in providing an in-home monitoring and communication system tailored for professional caregivers. Established in 2009 and based in Honolulu, Hawaii, the company offers a comprehensive data collection device that securely interfaces with web-based software, creating an integrated system for effective care management. Its flagship product, iHealthNavigator, equips clinical teams with tools to automate daily care management tasks and enhance client care coordination. The platform is designed for a variety of users, including home care agencies, complex care coordinators, residential care homes, senior living communities, and family caregivers. By connecting the entire care team and integrating workflows, iHealthHome enables secure digital record-keeping on mobile devices and facilitates the monitoring of patients’ health through sensors and wearable devices. The company operates as a subsidiary of Ho'okele Health Innovations, LLC.

Curb

Seed Round in 2020
Curb, Inc. is a company that develops a mobile application and web interface aimed at helping users monitor their electricity usage and manage their energy costs. Founded in 2012 and based in Austin, Texas, Curb provides an interactive energy efficiency solution that identifies energy consumption trends within homes, highlights energy-intensive appliances, and offers tips for saving energy. The platform empowers users to take control of their electricity bills and enhances their awareness of energy usage patterns.

SageMedic

Series A in 2020
SageMedic Corporation, based in Redwood City, California, specializes in developing innovative solutions for cancer treatment through its SAGE Direct Platform. Established in 2017, the company focuses on creating three-dimensional micro-tumors from live cancer tissue biopsies obtained from patients. This technology allows for direct testing of approved cancer therapies on the generated micro-tumors, enabling physicians to evaluate treatment responses and identify the most effective options for individual patients. By employing a genome-free approach, SageMedic aims to enhance precision medicine and improve patient outcomes in cancer therapy.

UbiQD

Series A in 2020
UbiQD, LLC is a cleantech materials company based in Los Alamos, New Mexico, that specializes in the production of low-hazard quantum dots and nanocomposites. Founded in 2014, UbiQD aims to make its innovative materials widely accessible for various applications, including agriculture, safety, design, solar energy, lighting, security, and personal care. The company offers UbiGro, a retrofit luminescent film designed to enhance crop growth by optimizing sunlight in greenhouses. UbiQD's low-toxicity quantum dots are engineered to efficiently convert light from one color to another, making them suitable for a range of industries while adhering to safety standards. The firm's strategic location near Los Alamos and Sandia National Laboratory facilitates valuable collaborations with leading scientists, furthering its mission to advance nanomaterial production and application.

Healionics

Series A in 2020
Healionics Corporation, founded in 2007 and based in Seattle, Washington, specializes in the development and manufacturing of synthetic biomaterials and implantable medical devices aimed at improving healthcare for kidney failure patients. The company has created STARport HD, an implantable device that enables needle-free access to the bloodstream for hemodialysis, and STARgraft, a synthetic vascular graft designed to maintain long-term blood flow without frequent interventions. Healionics' innovations address critical challenges in dialysis treatment, particularly the unreliability of current vascular access methods, which can lead to costly complications. Their STAR biomaterial technology enhances the performance of medical implants by reducing infection and scar tissue formation. Healionics is preparing to initiate human studies for its products, with a focus on improving patient outcomes and reducing overall treatment costs in the dialysis sector.

CLICS

Venture Round in 2020
CLiCS, LLC is a company that develops and markets an innovative computer-controlled color vending platform designed for hairdressers. Founded in 2016 and based in La Jolla, California, CLiCS offers a solution that enables salons to create, measure, mix, and dispense custom hair color shades efficiently. The platform enhances the precision of hair color formulation, eliminating guesswork by automating the mixing and dispensing processes. It also manages inventory and keeps records of color formulations, streamlining salon operations. By integrating artistry with advanced technology, CLiCS transforms the way hair color is formulated and managed in the beauty industry.

Soteria Battery Innovation Group

Series A in 2020
Soteria Battery Innovation Group is a technology development and licensing company focused on enhancing the safety of lithium-ion batteries. Founded in 2017 and headquartered in Greenville, South Carolina, Soteria has developed innovative technology that functions as an internal fuse within batteries to prevent ignition events. This advancement aims to make batteries inherently safe for a wide range of applications, from hearing aids to electric buses. The company is dedicated to ensuring that its safety materials are accessible to all battery manufacturers, promoting local production from a diverse supply base. By addressing fire risks in various devices, including drones, low-speed electric vehicles, power tools, and e-bikes, Soteria enables users to confidently utilize lithium-ion battery-powered devices.

OtoNexus Medical Technologies

Series C in 2020
OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of a patented ultrasound medical device aimed at diagnosing middle ear infections, also known as otitis media, in both children and adults. This innovative device provides clinicians with the ability to differentiate between viral and bacterial infections, facilitating informed decisions regarding the necessity of antibiotics. By employing ultrasound technology in a novel manner, the device delivers rapid diagnosis in seconds and can be utilized by various healthcare professionals, including physicians and non-physician personnel. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies was previously known as OtoMetrix Medical Technologies before rebranding in July 2014.

EternaTear

Series A in 2020
EternaTear, Inc. is focused on developing an innovative artificial tear solution aimed at addressing the challenges of dry eye syndrome. Based in Raleigh, North Carolina, the company has created EternaTear, a product designed to provide lubrication and therapeutic relief for individuals suffering from progressive dry eye. The solution utilizes a proprietary mechanism to supplement and bind the three layers of the tear film, enhancing stability and prolonging its presence on the ocular surface. This approach aims to mitigate the inadequate relief provided by existing over-the-counter options, which often require frequent reapplication and do not address the underlying causes of dry eye. By combining established technologies with novel research, EternaTear seeks to offer a more effective treatment that can significantly improve patients' quality of life and reduce symptoms associated with this condition.

b.well Connected Health

Venture Round in 2020
b.well Connected Health, Inc. is a healthcare technology company based in Baltimore, Maryland, with an additional location in Austin, Texas. Founded in 2015, the company has developed a healthcare application that consolidates and analyzes a consumer's healthcare data. This platform enables users to manage and share medical records and family health history while providing insights into financial aspects of their healthcare, such as benefit plans, co-pays, and deductibles. Additionally, it integrates data from wearables and self-reported sources to track various health metrics, including sleep, fitness, and nutrition. By offering an integrated solution tailored for health plans, health systems, employers, and pharmaceutical companies, b.well Connected Health seeks to empower individuals to optimize their healthcare experience and promote holistic health management.

InReality

Series A in 2020
InReality, LLC is a solution-as-a-service company specializing in retail analytics and customer experience optimization. Founded in 1995 and based in Cincinnati, Ohio, with additional offices in Atlanta and Hong Kong, InReality provides software and services that enhance shopper conversion for brands and retailers across various sectors, including beverage, home improvement, and electronics. The company's platform leverages IoT technology to deliver real-time analytics, which correlate point-of-sale data with metrics such as traffic, engagement, and product interaction. This enables clients to gain insights into consumer behavior and optimize their marketing strategies effectively. InReality also offers responsive technology solutions for personalized messaging and promotions, ensuring that retailers can engage shoppers in a timely and relevant manner. By integrating real-time triggers and automatic content updates across connected screens, InReality helps improve the overall customer experience and maximize return on investment for in-store marketing efforts.

Virion Therapeutics

Convertible Note in 2020
Virion Therapeutics, LLC is a biotechnology company focused on developing immune-based treatments for virally associated cancers and chronic viral infections. Founded in 2018 and headquartered in Newark, Delaware, the company offers innovative vaccines, ChiVax and ChiVax-gD, which aim to induce potent and sustained T cell-mediated immune responses against transformed or infected cells. These chimeric vaccine candidates have successfully completed pre-clinical testing, paving the way for clinical trials targeting diseases with significant unmet medical needs, such as HPV-induced cancers and chronic Hepatitis B infections. Virion Therapeutics combines scientific expertise with management experience to advance its immunotherapy platforms, which may ultimately improve patient outcomes in the fight against these challenging health issues.

Embera NeuroTherapeutics

Series A in 2020
Embera NeuroTherapeutics, Inc. is a pharmaceutical company based in Sudbury, Massachusetts, focused on developing innovative treatments for smoking cessation, cocaine dependence, and other addictions, areas that currently lack effective drug therapies. Founded in 2005, the company is advancing EMB-001, a novel addiction treatment that combines the benzodiazepine oxazepam with metyrapone, a cortisol synthesis inhibitor. This treatment targets the stress response system and specific brain functions associated with craving and relapse, aiming to modulate various stress-related pathways to alleviate the cravings that drive addictive behaviors. Embera NeuroTherapeutics is committed to addressing the significant challenges faced by individuals struggling with addiction by providing effective therapeutic options.

Steelhead Composites

Venture Round in 2020
Steelhead Composites LLC is an engineering and manufacturing company based in Golden, Colorado, specializing in lightweight hydraulic accumulators and high-pressure vessels for the hydraulic hybrid and energy storage markets. Founded in 2012, the company offers a range of services, including the manufacturing of aluminum cylinders, design and analysis of composite pressure vessels, and advanced filament winding techniques. Steelhead Composites also performs dynamic mechanical analysis, hydrostatic pressure testing, and precision 3D inspection of parts. With a fully digital shop floor and robust quality systems, the company competes in niche markets such as aerospace and hydrogen storage, providing safe and efficient solutions for storing and transporting gases in applications ranging from mobility to maritime.

KitoTech Medical

Convertible Note in 2020
KitoTech Medical is a medical device company based in Seattle, Washington, focused on developing and commercializing innovative products for wound closure and care. The company's flagship product, microMend, features a unique design that incorporates tiny Microstaples on an adhesive backing, resembling a butterfly bandage. This product is painless to apply and offers the holding strength of traditional sutures, making it suitable for closing surgical incisions and lacerations. Clinical studies indicate that microMend outperforms sutures in various clinical outcomes, including cosmetic results, and can be applied more quickly by a range of medical personnel, resulting in significant cost savings. microMend is marketed across numerous surgical specialties, as well as in dermatology and emergency medicine, with additional commercialization efforts targeting military applications. The potential market for microMend is substantial, estimated at over $600 million in the U.S. and around $2 billion globally. KitoTech Medical was founded in 2011.

Curvafix

Series B in 2020
CurvaFix, Inc. is a medical device company based in Bellevue, Washington, founded in 2017. The company focuses on developing innovative solutions for orthopedic trauma, specifically targeting pelvic fractures. Its flagship product, The CurvaFix, is an intramedullary rod screw designed to conform to the natural curvature of bones, effectively filling the space within curved structures such as the pelvis. By enabling surgeons to perform simpler and shorter procedures, CurvaFix aims to enhance patient recovery outcomes in the treatment of pelvic injuries.

LumiThera

Series C in 2020
LumiThera, Inc. is a medical device company dedicated to developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Founded in 2013 and based in Poulsbo, Washington, the company specializes in photobiomodulation therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular disorders. Its flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular conditions. LumiThera's technology not only strives to halt or slow the progression of vision-threatening diseases but also aims to enhance visual acuity and contrast sensitivity in patients. Through its advancements in light therapy, LumiThera supports healthcare providers in offering improved treatment options for individuals affected by these common eye disorders.

Defunkify

Convertible Note in 2020
Defunkify is a manufacturer of laundry cleaning and deodorizing products, specializing in solutions that effectively eliminate odors and stains from clothing and gear. Founded in 2017 and based in Eugene, Oregon, the company offers a range of products, including laundry detergent designed for activewear, as well as fabric and shoe deodorizers. Defunkify emphasizes the use of green chemistry to create high-performance products that are safer for consumers and the environment. Its offerings are available through various online platforms, including major retailers and its own website, ensuring a wide distribution across the United States. The innovative approach incorporates nano-engineered coatings that not only remove existing odors but also prevent them from returning, allowing users to wear clothing multiple times before needing to wash them.

Your Fare

Convertible Note in 2020
Your Fare, Inc., established in 2016 and based in San Francisco, California, specializes in developing an application that enables restaurants to manage all their online orders through a single platform. The company's ordering management system allows restaurateurs to consolidate orders from various sources, replace traditional online ordering tablets, and monitor daily sales via one dashboard. Additionally, Your Fare helps manage third-party delivery services, integrating them into a unified interface. This streamlined approach aims to enhance operational efficiencies and profit margins for restaurants by automating the handling of online meal orders and reducing order delivery time.

Kineta

Venture Round in 2020
Kineta, Inc. is a clinical stage biotechnology company based in Seattle, Washington, focused on the development of immunology-based therapeutics for oncology, neuroscience, and virology. The company is advancing a range of innovative therapies, including KCP-506, a non-opioid antagonist for chronic pain, and LHF-535, an oral antiviral targeting Lassa and other arenaviruses by inhibiting viral entry and replication. Kineta is also engaged in developing next-generation immunotherapies, exemplified by KVA12.1, a VISTA blocking immunotherapy designed to reprogram the immune system to combat cancer. With strategic partnerships with notable organizations like Pfizer and Genentech, Kineta aims to leverage its expertise in antiviral therapies and immune modulation to address significant medical challenges. Formerly known as Lecura, Inc., the company was founded in 2007.

StormSensor

Seed Round in 2020
StormSensor, Inc. is a company based in Seattle, Washington, that specializes in stormwater management solutions aimed at tracking and preventing flooding, sewage overflows, and other stormwater issues. Founded in 2015, it develops Scute sensors that provide real-time monitoring of stormwater systems. Additionally, StormSensor offers Terrapin, a cloud-based software platform that allows users to visualize data on maps and time-series, correlate it with real-time weather information, and receive alerts for significant flow events. This system automates workflow for inspections, data monitoring, and regulatory reporting, thereby helping clients streamline compliance processes in a complex regulatory environment. By providing critical insights into urban flooding, illicit discharges, and the impacts of climate change, StormSensor enables its clients to respond effectively to climate-driven risks and make informed decisions regarding infrastructure maintenance and improvements.

Inmedix

Seed Round in 2020
Inmedix, LLC is a company focused on developing diagnostics and therapeutics for autoimmune diseases by assessing and optimizing the autonomic nervous system's (ANS) control of stress responses in the brain. Founded in 2006 and located in Normandy Park, Washington, Inmedix has introduced a novel class of diagnostics and therapeutics aimed at understanding the relationship between ANS stress and autoimmune conditions. This approach, termed Immuno-autonomics, seeks to mitigate the exacerbating effects of stress on autoimmune diseases, enhancing the efficacy of existing therapies. Inmedix offers a cloud-based software platform along with diagnostic devices that track the interaction between stress and immune function, providing valuable insights for clinicians and opportunities in drug discovery.

Turn Technologies

Convertible Note in 2020
Turn Technologies, Inc. is a Chicago-based company that specializes in developing an AI-powered workforce-as-a-service platform aimed at managing workers. Founded in 2016, the company focuses on hiring hourly, shift-based, and contracted workers, utilizing advanced screening and AI sourcing techniques. Its platform is designed for speed and accuracy, offering features such as mobile-friendly services, seamless API and HR integration, flexibility in planning, comprehensive candidate profiles, and built-in support tools. This comprehensive approach allows companies to efficiently source, screen, and retain workers, enhancing their workforce management capabilities.

CLICS

Convertible Note in 2020
CLiCS, LLC is a company that develops and markets an innovative computer-controlled color vending platform designed for hairdressers. Founded in 2016 and based in La Jolla, California, CLiCS offers a solution that enables salons to create, measure, mix, and dispense custom hair color shades efficiently. The platform enhances the precision of hair color formulation, eliminating guesswork by automating the mixing and dispensing processes. It also manages inventory and keeps records of color formulations, streamlining salon operations. By integrating artistry with advanced technology, CLiCS transforms the way hair color is formulated and managed in the beauty industry.

HaptX

Convertible Note in 2020
HaptX develops advanced virtual reality gloves that simulate touch sensation with remarkable realism. By utilizing patented microfluidic technology, HaptX Gloves offer 130 points of touch feedback and provide resistive force feedback of 4 lbs. per finger while tracking hand motions with sub-millimeter precision. This innovative device creates a haptic experience that allows users to perceive the texture, shape, motion, vibration, and temperature of virtual objects, enhancing interaction within the virtual environment. Founded by Jake Rubin and Dr. Bob Crockett, HaptX operates with a team of 35 employees across offices in Seattle, Washington, and San Luis Obispo, California.

b.well Connected Health

Convertible Note in 2020
b.well Connected Health, Inc. is a healthcare technology company based in Baltimore, Maryland, with an additional location in Austin, Texas. Founded in 2015, the company has developed a healthcare application that consolidates and analyzes a consumer's healthcare data. This platform enables users to manage and share medical records and family health history while providing insights into financial aspects of their healthcare, such as benefit plans, co-pays, and deductibles. Additionally, it integrates data from wearables and self-reported sources to track various health metrics, including sleep, fitness, and nutrition. By offering an integrated solution tailored for health plans, health systems, employers, and pharmaceutical companies, b.well Connected Health seeks to empower individuals to optimize their healthcare experience and promote holistic health management.

SST Wireless

Series A in 2020
SST Wireless Inc. specializes in the design, manufacture, and distribution of wireless sensor technologies aimed at enhancing safety, conserving energy, and minimizing operational downtime for vehicles and equipment. The company offers a range of products, including advanced vibration sensors, high-temperature sensors capable of withstanding extreme conditions, and pressure sensors designed for harsh environments. Their wireless sensor systems are particularly recognized in the field of tire pressure monitoring for heavy-duty vehicles like mine haul trucks and construction equipment. In addition to their sensor products, SST Wireless provides a monitoring software platform that facilitates real-time data analysis, helping clients make informed decisions to improve safety and efficiency. Established in 2002 and headquartered in Richmond, Canada, SST Wireless also offers integration, support, and custom development services to accommodate various client needs.

HaptX

Series A in 2019
HaptX develops advanced virtual reality gloves that simulate touch sensation with remarkable realism. By utilizing patented microfluidic technology, HaptX Gloves offer 130 points of touch feedback and provide resistive force feedback of 4 lbs. per finger while tracking hand motions with sub-millimeter precision. This innovative device creates a haptic experience that allows users to perceive the texture, shape, motion, vibration, and temperature of virtual objects, enhancing interaction within the virtual environment. Founded by Jake Rubin and Dr. Bob Crockett, HaptX operates with a team of 35 employees across offices in Seattle, Washington, and San Luis Obispo, California.

Embera NeuroTherapeutics

Series B in 2019
Embera NeuroTherapeutics, Inc. is a pharmaceutical company based in Sudbury, Massachusetts, focused on developing innovative treatments for smoking cessation, cocaine dependence, and other addictions, areas that currently lack effective drug therapies. Founded in 2005, the company is advancing EMB-001, a novel addiction treatment that combines the benzodiazepine oxazepam with metyrapone, a cortisol synthesis inhibitor. This treatment targets the stress response system and specific brain functions associated with craving and relapse, aiming to modulate various stress-related pathways to alleviate the cravings that drive addictive behaviors. Embera NeuroTherapeutics is committed to addressing the significant challenges faced by individuals struggling with addiction by providing effective therapeutic options.

Electric Playhouse

Series A in 2019
Electric Playhouse, Inc. is an entertainment company based in Albuquerque, New Mexico, which was incorporated in 2018. It operates a public venue that provides immersive and interactive experiences suitable for all ages. The facility features an indoor experiential center that blends physical and digital elements, offering a variety of games, dining options, and special events. The venue is designed to create engaging environments, highlighted by neon lighting and a diverse range of activities that encourage socialization and rejuvenation among guests.

Varidi

Seed Round in 2019
Varidi, Inc. is a company that specializes in a cloud-based payment platform aimed at helping businesses offer flexible financing options directly to consumers. Founded in 2013 and headquartered in Woodinville, Washington, Varidi's platform provides a comprehensive suite of payment and cash flow solutions, allowing businesses to streamline payment processes through e-invoicing, pay-now, and pay-overtime options. This system not only simplifies the management of payment plans with automated invoicing but also reduces administrative burdens, thereby lowering overhead costs and minimizing bad debt. By enabling businesses to offer diverse payment options, Varidi supports increased revenue generation and customer loyalty.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.